tirzepatide jama Combined and Ixekizumab Therapy Shows Dual Benefits in Psoriasis: Semaglutide vs Tirzepatide for Weight

It remains investigational, with approval not expected before late 2027

In the pivotal SURMOUNT-1 trial, participants without diabetes who took tirzepatide for 72 weeks lost an average of 16% of body weight at the 5 mg dose, 21.4% at the 10 mg dose, and 22.5% at the 15 mg dose, compared to just 2.4% in the placebo group

Protein window: 2040 g protein within 12 hours if training

Nitrous oxide lawsuit claims center on manufacturers, distributors, and retailers who profit from selling canisters that are widely misused as a recreational drug

Instead, it helps establish healthier dietary habits and break unhealthy cycles influenced by marketing and processed foods